This week, we review the major flagship anti-VEGF agents, pegaptinib, ranibizumab, bevacizumab, aflibercept, as well as some of the flagship clinical trials, including VISION, MARINA, ANCHOR, CATT, and VIEW 1 and 2.
Also, we are doing a survey to assess the impact of the podcast. If you'd like to support us, take this 4 minute survey: bit.ly/2VpPRND
Buddy Call-The 20 Point Exam and Red Eyes with Dr. Paul Gaudio!
Lenticular Glaucomas
Macular Holes with Dr Jay Sridhar!
Acute Anterior Uveitis Part 2
Acute Anterior Uveitis Part 1
Atypical Optic Neuritis
Optic Neuritis
Color Vision Deficiency
Ectopia Lentis
EfE Chats with Andrea Tooley, MD!
Ocular Syphilis
Macular Dystrophies
Sickle Cell Retinopathy (+ other manifestations)
Landmark Glaucoma Trials
Nystagmus II + Saccadia
Corneal Dystrophies II + Ectasias
Nystagmus I
Corneal Dystrophies I
Phakomatoses II
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive